1. “Virtual reality immersion: Enhancing physician-patient communication to promote value-based care.” Investigators: Dr. Lea Brandt PhD, Dr. Julia Halsey MD
  2. “Optimizing inhaler device selection to improve compliance and inhaler technique among patients with obstructive lung disease. “Investigators: Dr. Armin Krvavac, Dr. Chris Boyer, Dr. Tarang Patel, and Dr. Ethan Karle
  3. Use of Contemporary technologies to Prevent DKA readmission S. Hasan Naqvi, MD1 FNU Marium, MD1, Timur Gusov, MD1 Division of Hospital Medicine, Department of Medicine, University of Missouri-Columbia.
  4. Leveraging telemedicine technology to fight against opioid epidemic: S. Hasan Naqvi, MD, Budgeted Price, MS, Dr. Oluwole Popoola, MD
  5. Implementation of Interdisciplinary Group Therapies in “Integrated Medicine UNIT” to prevent Delirium in high-risk population: Dr. Illhoi Yoo PhD, S. Hasan Naqvi, MD
  6. Improving Patient Tobacco Use Outcomes by Providing Treatment for Hospitalized Patients: Dr. Kevin Everett, Dr. Eric Kimchi, Dr. S. Hasan Naqvi
  7. Project title: Identifying transitional care interventions on hospital readmission from the literature Dr. Illhoi Yoo PhD, S. Hasan Naqvi, MD
  8. Improving Acute and Chronic Pain Management Using Mobile Technologies and Gamification for Low Socioeconomic Status and Rural Populations Role Dr. Illhoi Yoo PhD, S. Hasan Naqvi, MD
  9. Phase 3 double blinded, placebo controlled RCT Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine Trial (HERO-HCQ Trial) Sponsor PCOR-Network : Site Principal Investigator, S. Hasan Naqvi
  10. Phase 3 Multicenter, Randomized, Double Blind, -Placebo Controlled, -Parallel Group- Study to Evaluate the Safety, Tolerability, and Efficacy of SER-109 vs. Placebo to Reduce Recurrence of Clostridium difficile Infection (CDI) in Adults Who Have Received Antibacterial Drug Treatment for Recurrent CDI (RCDI) SERES-012: ECOSPOR III: A Site Principal Investigator, S. Hasan Naqvi
  11. AN OPEN-LABEL EXTENSION OF STUDY SERES-012 EVALUATING SER-109 IN ADULT SUBJECTS WITH RECURRENT CLOSTRIDIUM DIFFICILE INFECTION (RCDI) SERES-013: ECOSPOR IV Site Principal Investigator, S. Hasan Naqvi